REVUE DE PRESSE (sources en français)
30-Jan-2016 – 18h00 CET: Pierre Jérôme revient sur la stratégie et les perspectives de SpineGuard suite à un exercice 2016 solide et à l’autorisation de commercialisation pour sa vis intelligente aux États-Unis. Interview du Cofondateur et Directeur général de SpineGuard sur La bourse et la vie, Web Tv Biomed Event 2017 (Voir la vidéo)
REVUE DE PRESSE (sources en anglais)
18-Apr-2018: Professor Yong QIU, Chairman of Orthopedic Surgery of Nanjing Drum Tower Hospital, performed the first surgery in China with the PediGuard® in spinal deformity. If you want to know more, watch the video.
01-Mar-2016: Pierre Jerome, SpineGuard’s CEO and co-founder, was invited to speak at the Canaccord Genuity Musculoskeletal Conference in Orlando, Florida, on March 1, 2016. He shared SpineGuard’s vision during his presentation, where he says, “there is a real need for innovation and differentiation in the spine space where pedicle screws are used”. This presentation and the Q&A that followed was webcast live. A recording of the webcast can be accessed by clicking here.
21-Jul-2013: SpineGuard – Taming the Screw: Much of the innovation in spine over the past decade has aimed at replacing fusion, still the standard of care. SpineGuard’s novel sensor technology is betting on fusion’s long-term prospects, helping patients and surgeons by making the procedure safer. Read more… (pdf version)
29-Apr-2013: SpineGuard (EPA:ALSGD) said its initial public offering on Europe’s Alternext exchange raised some €8.1 million, or roughly $10.5 million. The Paris-based medical device company makes the PediGuard device, designed to help guide the placement of pedicle screws during spinal fusion surgeries. Read more…